Related Experiment Video
Updated: May 12, 2026

10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Pathway-based personalized analysis of cancer
Yotam Drier1, Michal Sheffer, Eytan Domany
1Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot 76100, Israel.
Summary
Pathifier is a new algorithm that analyzes gene expression data to calculate pathway deregulation scores for cancer samples. This method helps identify cancer subtypes and predict patient survival in colorectal cancer and glioblastoma.
Area of Science:
- Bioinformatics
- Computational Biology
- Cancer Genomics
Background:
- Gene expression data is crucial for understanding cancer biology.
- Existing methods may not effectively capture pathway-level alterations.
- A need exists for robust algorithms to translate gene data into actionable biological insights.
Purpose of the Study:
- To introduce Pathifier, an algorithm for inferring pathway deregulation scores from gene expression data.
- To provide a context-specific, sample-level representation of pathway activity.
- To demonstrate Pathifier's utility in cancer research.
Main Methods:
- Developed Pathifier algorithm to transform gene-level expression data into pathway-level deregulation scores.
- Applied the algorithm to multiple colorectal cancer and glioblastoma multiforme datasets.
- Validated the reproducibility and information preservation of the multipathway representation.
Main Results:
- Pathifier generates reproducible and informative pathway-based sample representations.
- Identified significant pathways associated with glioblastoma patient survival.
- Discovered two pathways (CXCR3-mediated signaling, oxidative phosphorylation) predictive of colorectal cancer survival.
- Identified novel glioblastoma and colon cancer subclasses with distinct survival outcomes.
Conclusions:
- Pathifier effectively infers pathway deregulation scores, offering a compact and biologically relevant representation of tumor samples.
- The algorithm facilitates the discovery of novel biomarkers and cancer subtypes linked to patient survival.
- Pathifier enhances our understanding of cancer heterogeneity and provides a foundation for personalized medicine approaches.
Related Concept Videos
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
